Patient and citizen participation at the organisational level in health technology assessment: an exploratory study in five jurisdictions

8 August 2023 - While patient participation in individual health technology assessments has been frequently described in the literature, patient and ...

Read more →

Belgium may remove step between paying doctors and reimbursement

8 October 2021 - Doctors and dentists could soon choose to only charge patients for co-payments – the non-refundable part ...

Read more →

Minister for Health announces HSE approval to reimburse Zolgensma (onasemnogene abeparvovec) as part of a joint BeNeLuxA collaboration

8 October 2021 - Following the first joint agreement on the price of a drug between Belgium, Ireland and the ...

Read more →

New cancer drugs are expensive and often ineffective

5 July 2021 - Many of the new cancer drugs coming onto the market in Belgium are too expensive, and ...

Read more →

Belgium seeks to encourage generic drugs with new prescription reimbursement structure

18 May 2021 - The federal government has decided to increase the percentage by which generic drugs will be reimbursed, ...

Read more →

High Council for Health calls for reimbursement for ADHD medication

5 May 2021 - The High Council for Health has issued a formal opinion calling for medication used in the treatment ...

Read more →

Evaluation of precision medicine assessment reports of the Belgian health care payer to inform reimbursement decisions

7 September 2020 - Precision medicines rely on companion diagnostics to identify patient subgroups eligible for receiving the pharmaceutical product.  ...

Read more →

Flemish Alzheimerliga wants to maintain reimbursement of Alzheimer’s disease medication

14 October 2019 - The Flemish Alzheimerliga, that represents patients with Alzheimer’s disease and their families, is against the National ...

Read more →

Baby Pia: almost 1 million Belgians pay for life-saving drug

18 September 2019 - More than 950,000 Belgians have responded to a couple seeking €1.9m ($2m; £1.7m) to cover the ...

Read more →